Mission Wealth Management »

Corvus Pharmaceuticals shares owned by Mission Wealth Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Mission Wealth Management from 13F filings

Historical chart of Mission Wealth Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Mission Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Mission Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $211k 40k 5.28

More positions owned by Mission Wealth Management

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio Intrmd (SPIB)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Wisdomtree Tr Floatng Rat Trea (USFR)
Ishares Tr Msci Usa Esg Slc (SUSA)
The Trade Desk Com Cl A (TTD)
Amazon (AMZN)

View all positions for Mission Wealth Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
Point72 Asset Management
Samlyn Capital
Vanguard Group
BlackRock
Geode Capital Management
BlackRock
Renaissance Technologies
Morgan Stanley
Schonfeld Strategic Advisors
Marshall Wace
Susquehanna International
Ikarian Capital
Citadel Advisors
Connor, Clark & Lunn Investment Management

View all funds holding Corvus Pharmaceuticals